Cognizant collaborates with medidata to provide specialized support for life sciences clients

The organizations plan to support clients through expanded partnership and offer broader access to medidata's ai-powered technologies to accelerate clinical trial development teaneck, n.j. , jan. 30, 2025 /prnewswire/ -- cognizant (nasdaq: ctsh) announced an expanded agreement with medidata, a dassault systÈmes brand and leader of clinical trial solutions to the life sciences industry, to provide support for medidata's life sciences clients and expand the strategic alliance partnership.
CTSH Ratings Summary
CTSH Quant Ranking